- Patent Title: Modified immunoglobulin hinge regions to reduce hemagglutination
-
Application No.: US17223778Application Date: 2021-04-06
-
Publication No.: US11760810B2Publication Date: 2023-09-19
- Inventor: Jie Liu , Irving L. Weissman , Ravindra Majeti
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela J. Sherwood
- The original application number of the division: US16340537
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K14/705 ; C07K16/28 ; A61K38/00

Abstract:
Polypeptide compositions comprising a human immunoglobulin constant region with a modified IgG4 hinge region having an N-terminal deletion of 1, 2, 3, 4, 5 amino acids, relative to a native human IgG4 hinge sequence are provided. In some embodiments the hinge sequence further comprises the amino acid substitution S228P (Eu numbering). Polypeptides comprising the modified sequence optionally comprise a binding moiety specific for an epitope that is present on red blood cells; and can provide for reduced agglutination of hematopoietic cells compared to a comparable polypeptide with a native hinge region.
Public/Granted literature
- US20210253740A1 MODIFIED IMMUNOGLOBULIN HINGE REGIONS TO REDUCE HEMAGGLUTINATION Public/Granted day:2021-08-19
Information query